These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 3802743)
1. Exploitation of the direct cell damaging action of antifungal azoles. Beggs WH; Hughes CE Diagn Microbiol Infect Dis; 1987 Jan; 6(1):1-3. PubMed ID: 3802743 [No Abstract] [Full Text] [Related]
2. The biology and chemistry of antifungal agents: a review. Kathiravan MK; Salake AB; Chothe AS; Dudhe PB; Watode RP; Mukta MS; Gadhwe S Bioorg Med Chem; 2012 Oct; 20(19):5678-98. PubMed ID: 22902032 [TBL] [Abstract][Full Text] [Related]
3. Use of amphotericin B with azole antifungal drugs: what are we doing? Sugar AM Antimicrob Agents Chemother; 1995 Sep; 39(9):1907-12. PubMed ID: 8540690 [No Abstract] [Full Text] [Related]
5. Fungal cell membrane-promising drug target for antifungal therapy. Sant DG; Tupe SG; Ramana CV; Deshpande MV J Appl Microbiol; 2016 Dec; 121(6):1498-1510. PubMed ID: 27667746 [TBL] [Abstract][Full Text] [Related]
6. Fenticonazole: a new antifungal imidazole derivative in vitro and in vivo antimycotic activity. Veronese M; Barzaghi D; Bertoncini A; Cornelli U Mykosen; 1984 Apr; 27(4):194-202. PubMed ID: 6727923 [No Abstract] [Full Text] [Related]
7. Eberconazole. WAS 2160. Drugs R D; 1999 Feb; 1(2):168-9. PubMed ID: 10566015 [No Abstract] [Full Text] [Related]
8. Azole antimycotics--a highway to new drugs or a dead end? Musiol R; Kowalczyk W Curr Med Chem; 2012; 19(9):1378-88. PubMed ID: 22257053 [TBL] [Abstract][Full Text] [Related]
9. Fundamental Concepts of Azole Compounds and Triazole Antifungals: A Beginner's Review. Martínez-Matías N; Rodríguez-Medina JR P R Health Sci J; 2018 Sep; 37(3):135-142. PubMed ID: 30188556 [TBL] [Abstract][Full Text] [Related]
10. Is there a serious risk of resistance development to azoles among fungi due to the widespread use and long-term application of azole antifungals in medicine? Hof H Drug Resist Updat; 2008; 11(1-2):25-31. PubMed ID: 18325827 [TBL] [Abstract][Full Text] [Related]
16. In vitro susceptibility of non-Aspergillus allergenic fungal species to azoles. Duddy NE; Moore CB; Howard SJ; Denning DW J Antimicrob Chemother; 2009 Apr; 63(4):834-6. PubMed ID: 19221103 [No Abstract] [Full Text] [Related]
17. Novel alkylated azoles as potent antifungals. Shrestha SK; Garzan A; Garneau-Tsodikova S Eur J Med Chem; 2017 Jun; 133():309-318. PubMed ID: 28395217 [TBL] [Abstract][Full Text] [Related]
18. Medically important fungi respond to azole drugs: an update. Zavrel M; White TC Future Microbiol; 2015; 10(8):1355-73. PubMed ID: 26234644 [TBL] [Abstract][Full Text] [Related]
19. Unpredictable susceptibility of emerging clinical moulds to tri-azoles: review of the literature and upcoming challenges for mould identification. Araujo R; Oliveira M; Amorim A; Sampaio-Maia B Eur J Clin Microbiol Infect Dis; 2015 Jul; 34(7):1289-301. PubMed ID: 25894985 [TBL] [Abstract][Full Text] [Related]
20. [Basis of antifungal chemotherapy]. Arai T; Uno H Nihon Saikingaku Zasshi; 1983; 38(2):525-48. PubMed ID: 6350637 [No Abstract] [Full Text] [Related] [Next] [New Search]